Literature DB >> 16503115

Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus.

Juan-Manuel Anaya1, John Castiblanco, Gabriel J Tobón, Jorge García, Verónica Abad, Héctor Cuervo, Alejandro Velásquez, Ivan D Angel, Patricia Vega, Alvaro Arango.   

Abstract

We investigated the familial aggregation of autoimmune diseases (AIDs) among first-degree relatives (FDR) of patients with type 1 diabetes mellitus (T1D). Relatives of 98 T1D patients defined according to the guidelines diagnosis of the American Diabetes Association and 113 matched controls without any AID, were interviewed using a questionnaire that sought information about demographic and medical characteristics including a list of 18 AIDs. Genetic analysis was performed using the program ASSOC and by calculating recurrent risk ratios. In cases, 25.5% of the families had at least one member having an AID, while in controls there were 9% (odds ratio [OR]: 3.96, 95% confidence interval [CI]=1.74-9.0, p=0.0006). An AID was registered in 8.3% of 312 FDR of patients as compared with 2.4% of 362 FDR in controls (OR: 3.56, 95% CI=1.64-7.73, p=0.0008). The most frequent AIDs registered in FDR of cases were autoimmune thyroid disease (AITD) and T1D, which disclosed coefficients of aggregation. These results indicate that AIDs cluster within families of T1D patients adding further evidence to consider that clinically different autoimmune phenotypes may share common susceptibility gene variants, which may act pleiotropically as risk factors for autoimmunity.

Entities:  

Mesh:

Year:  2006        PMID: 16503115     DOI: 10.1016/j.jaut.2006.01.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  32 in total

Review 1.  Autoimmune/inflammatory syndrome induced by adjuvant (ASIA) evolution after silicone implants. Who is at risk?

Authors:  Idan Goren; Gad Segal; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2015-04-16       Impact factor: 2.980

2.  Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases.

Authors:  Amit K Maiti; Xana Kim-Howard; Parvathi Viswanathan; Laura Guillén; Xiaoxia Qian; Adriana Rojas-Villarraga; Celi Sun; Carlos Cañas; Gabriel J Tobón; Koichi Matsuda; Nan Shen; Alejandra C Cherñavsky; Juan-Manuel Anaya; Swapan K Nath
Journal:  Rheumatology (Oxford)       Date:  2010-03-24       Impact factor: 7.580

3.  Dermal immunopathology: from genetics to effector mechanisms.

Authors:  Akira Takashima; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

4.  Epidemiology of autoimmune diseases in Denmark.

Authors:  William W Eaton; Noel R Rose; Amanda Kalaydjian; Marianne G Pedersen; Preben Bo Mortensen
Journal:  J Autoimmun       Date:  2007-06-19       Impact factor: 7.094

Review 5.  A propos time and autoimmunity.

Authors:  Pablo I Martín; Ana I Malizia; E Rewald
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

6.  Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives.

Authors:  Susan L Neuhausen; Linda Steele; Sarah Ryan; Maryam Mousavi; Marie Pinto; Kathryn E Osann; Pamela Flodman; John J Zone
Journal:  J Autoimmun       Date:  2008-08-08       Impact factor: 7.094

7.  Dissecting the role of the FOXP3 gene in the joint genetic susceptibility to autoimmune thyroiditis and diabetes: a genetic and functional analysis.

Authors:  Cheuk Wun Li; Erlinda Concepcion; Yaron Tomer
Journal:  Gene       Date:  2014-12-03       Impact factor: 3.688

8.  Familial type 1 diabetes mellitus - gender distribution and age at onset of diabetes distinguish between parent-offspring and sib-pair subgroups.

Authors:  Yael Lebenthal; Liat de Vries; Moshe Phillip; Liora Lazar
Journal:  Pediatr Diabetes       Date:  2009-12-02       Impact factor: 4.866

Review 9.  Hepatitis B virus (HBV) and autoimmune disease.

Authors:  Ram Maya; M Eric Gershwin; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

10.  Whither autoimmunity: the lessons of anti-CCP and B cell depletion.

Authors:  Yehuda Shoenfeld; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.